Influence of metabolic genotypes on biomarkers of exposure to 1, 3-butadiene in humans

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 10, 2002, Pages 1082-1090

  Fustinoni, Silvia ^a   Soleo, Leonardo ^b   Warholm, Margareta ^c   Begemann, Petra ^d,e   Rannug, Agneta ^c   Neumann, Hans G ^d   Swenberg, James A ^e   Vimercati, Luigi ^b   Foà, Vito ^f   Colombi, Antonio ^f  

^a PARKINSON INSTITUTE   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e University of North Carolina at Chapel Hill   (United States)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; ALCOHOL DEHYDROGENASE; BIOLOGICAL MARKER; CYSTEINE DERIVATIVE; CYTOCHROME P450 2E1; EPOXIDE; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; HEMOGLOBIN DERIVATIVE; VALINE;

ADULT; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTOXICITY; GENOTYPE; HUMAN; MALE; METABOLIC ACTIVATION; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SMOKING; URINE LEVEL;

ADULT; ALCOHOL DEHYDROGENASE; BUTADIENES; CARCINOGENS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2E1; DNA ADDUCTS; GENETIC MARKERS; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HEMOGLOBINS; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; SMOKING;

EID: 0036800703     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. American Conference of Governmental Industrial Hygienists. Threshold Limit Values and Biological Exposure Indices. Cincinnati, OH: ACGIH 2000
2. Deutsche Forschungsgemeinschaft. List of MAK and BAT Values. Commission for the Investigation of Health Hazard of Chemical Compounds in the Work Area, Report 35. Weinheim, DE: Wiley-VCH, 1999
3. Brunnemann, K. D., Kagan, M. R., Cox, J. E., and Hoffmann, D. Analysis of 1.3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis (Lond.), 11: 1863-1868, 1990
4. Löfgren, L., and Petersson, G. Butenes and butadiene in urban air. Sci. Total Environ., 116: 195-201, 1992
5. Kim, Y. M., Harrad, S., and Harrison, R. M. Concentration and sources of VOCs in urban domestic and public microenvironments. Environ. Sci. Technol., 35: 997-1004, 2001
6. IARC. 1, 3-Butadiene. In: International Agency for Research on Cancer, Vol. 71, pp. 109-225. Lyon, France: WHO, 1999
7. Department of Health and Human Services. The Ninth Report on Carcinogens. Research Triangle Park, NC: National Toxicology Program, 2000
8. Csanady, G. A., Guengerich, F. P., and Bond, J. A. Comparison of the biotransformation of 1, 3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis (Lond.), 13: 1143-1153, 1992
9. Duescher, R. J., and Elfarra, A. A. Human liver microsomes are efficient catalyst of 1, 3-butadiene oxidation: evidence for major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys., 311: 342-349, 1994
10. Seaton, M. J., Follansbee, M. H., and Bond, J. A. Oxidation of 1, 2-epoxy-3-butene to 1, 2:3, 4-diepoxybutane by cDNA-expressed human cytochrome P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis (Lond.), 16: 2287-2293, 1995
11. Richardson, K. A., Megens, H. J., Webb, J. D., and van Sittert, N. J. Biological monitoring of butadiene exposure by measurement of haemoglobin adducts. Toxicology, 113: 112-118, 1996
12. Osterman-Golkar, S. M., Moss. O., James, A., Bryant, M. S., Turner, M., and Bond, J. A. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene. Toxicol. Appl. Pharmacol., 150: 166-173, 1998
13. Begemann, P., Srám, R. J., and Neumann, H. G. Hemoglobin adducts of epoxybutene in workers occupationally exposed to 1, 3-butadiene. Arch. Toxicol., 74: 680-687, 2001
14. Begemann, P., Upton, P. B., Ranasinghe, A., Swenberg, J. A., Soleo, L., Vimercati, L., Gelormini, A., Fustinoni, S., Zwirner-Baier, I., and Neumann, H. G. Hemoglobin adducts as biomarkers of 1, 3-butadiene in occupationally low exposed Italian workers and a few diesel-exposed miners. Chem. Biol. Interact., 135-136: 675-678, 2001
15. Koivisto, P., Kilpalainen, I., Rasanes, I., Adler, I. D., Pacchierotti, F., and Peltonen, K. Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: a high occurrence of diolepoxide-derived adducts in mouse lung after 1, 3-butadiene exposure. Carcinogenesis (Lond.), 20: 1253-1259, 1999
16. Zhao, C., Vodicka, P., Srám, R. J., and Hemminki, K. Human DNA adducts of 1, 3-butadiene, an important environmental carcinogen. Carcinogenesis (Lond.), 21: 107-111, 2000
17. Jackson, M. A., Stack, H. F., Rice, J. M., and Waters, M. D. A review of the genetic and related effects of 1, 3-butadiene in rodents and humans. Mutat. Res., 463: 181-213, 2000
18. Boogaard, P. J., and Bond, J. A. The role of hydrolysis in the detoxification of 1, 2:3, 4-diepoxybutane by human, rat, and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol., 141: 617-627, 1996
19. 13C]butadiene. Chem. Res. Toxicol., 9: 764- 773, 1996
20. Richardson, K. A., Peters, M. M., Wong, B. A., Megens, H. J., van Elburg, P. A., Booth, E. D., Boogaard, P. J., Bond, J. A., Medinsky, M. A., Watson, W. P., and van Sittert, N. J. Quantitative and qualitative differences in the metabolism of 14C-1, 3-butadiene in rats and mice: relevance to cancer susceptibility. Toxicol. Sci., 49: 186-201, 1999
21. Bechtold, W. E., Strunk, M. R., Chang, I. Y., Ward, J. B., and Henderson, R. F. Species differences in urinary butadiene metabolites: comparison of metabolite ratio between mice, rats and humans. Toxicol. Appl. Pharmacol., 127: 44-49, 1994
22. Kemper, R. A., Elfarra, A. A., and Myers, S. R. Metabolism of 3-butene-1, 2-diol in B6C3F1 mice. Evidence for involvement of alcohol dehydrogenase and cytochrome P450. Drug Metab. Dispos., 26: 914-920, 1998
23. Himmelstein, M. W., Acquavella, J. F., Recio, L., Medinsky, M. A., and Bond, J. A. Toxicology and epidemiology of 1, 3-butadiene. Crit. Rev. Toxicol., 27: 1-108, 1997
24. Himmelstein, M. W., Turner, M. J., Asgharian, B., and Bond, J. A. Comparison of blood concentrations of 1, 3-butadiene and butadiene epoxides in mice and rats exposed to 1, 3-butadiene by inhalation. Carcinogenesis (Lond.), 15: 1479-1786, 1994
25. Himmelstein, M. W., Asgharian, B., and Bond, J. A. High concentrations of butadiene epoxides in liver and lungs of mice compared to rats exposed to 1, 3-butadiene. Toxicol. Appl. Pharmacol., 132: 281-288, 1995
26. Bond, J. A., and Medinsky, M. A. Insight into the toxicokinetics and toxicodynamics of 1, 3-butadiene. Chem. Biol. Interact., 135-136: 599-614, 2001
27. Albertini, R. J., Srám, R. J., Vacek, P., Lynch, J., Wright, M., Nicklas, J. A., Boogaard, P. J., Henderson, R. F., Swenberg, J. A., Tates, A. D., and Ward, J. B. Biomarkers for assessing occupational exposures to 1, 3-butadiene. Chem. Biol. Interact., 135-136: 429-453, 2001
28. Hayes, R. B., Zhang, L., Yin, S., Swenberg, J. A., Xi, L., Wiencke, J., Bechtold, W. E., Yao, M., Rothman, N., Haas, R., O'Neil, J. P. O., Zhang, D., Wielmels, J., Dosemeci, M., Li, G., and Smith, M. T. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis (Lond.), 21: 55-62, 2000
29. van Sittert, N. J., Megens, H. J., Watson, W. P., and Boogaard, P. J. Biomarkers of exposure to 1, 3-butadiene as a basis for cancer assessment. Toxicol. Sci., 56: 189-202, 2000
30. Ward, J. B., Ammenheuser, M. M., Whorton, E. B., Bechtold, W. E., Kelsey, K. T., and Legator, M. S. Biological monitoring for mutagenic effects of occupational exposure to butadiene. Toxicology, 113: 84-90, 1996
31. Hallberg, L. M., Bechtold, W. E., Grandy, J., Legator, M. S., and Au, W. W. Abnormal DNA repair activities in lymphocytes of workers exposed to 1, 3-butadiene. Mutat. Res., 383: 213-221, 1997
32. Kelsey, K. T., Wienkle, J. K., Ward, J. B., Bechtold, W. E., and Fajen, J. Sister-chromatid exchanges, glutathione S-transferase θ deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat. Res., 335: 267-273, 1995
33. van Sittert, N. J., and van Vliet, E. W. N. Monitoring occupational exposure to some industrial chemicals by determining hemoglobin adducts. Clin. Chem., 40: 1472-1475, 1994
34. Licea Pérez, H., Lähdetie, J., Landin, H. H., Kilpeläinen, I., Koivisto, P., Peltonen, K., and Osterman-Golkar, S. Haemoglobin adducts of epoxybutanediol from exposure to 1, 3-butadiene or butadiene epoxides. Chem. Biol. Interact., 105: 181-198, 1997
35. Swenberg, J. A., Christova-Gueorguieva, N. I., Upton, P. B., Ranasinghe, A., Scheller, N., Wu, K. Y., Yen, T. Y., and Hayes, R. Hemoglobin adducts as biomarkers of 1, 3-butadiene exposure and metabolism. In: 1, 3-Butadiene: Cancer, Mutations, and Adducts. Cambridge, MA, Health Effects Institute, Research Report 92, pp. 191-210, 2000
36. Norppa, H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ. Health Perspect., 105 (Suppl. 4): 829-835, 1997
37. Bernardini, S., Hirvonen, A., Pelin, K., and Norppa, H. Induction of sister chromatid exchange by 1, 2-epoxy-3-butene in cultured human lymphocytes: influence of GSTT1 genotype. Carcinogenesis (Lond.), 19., 377-380, 1998
38. Vlachodimitropoulos, D., Norppa, H., Autio, K., Catalán, J., Hirvonen, A., Tasa, G., Uusküla, M., Demopoulos, N. A., and Sorsa, M. GSTT1-dependent induction of centromere-negative and -positive micronuclei by 1, 2:3, 4-diepoxybutane in cultured human lymphocytes. Mutagenesis, 12: 397-403, 1997
39. Norppa, H., Hirvonen, A., Järventaus, H., Uusküla, M., Tasa, G., Ojajärvi, A., and Sorsa, M. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane cultured human lymphocytes. Carcinogenesis (Lond.), 16: 1261-1264, 1995
40. Landi, S., Norrpa, H., Frenzilli, G., Cipollini, G., Ponzanelli, I, Barale, R., and Hirvonen, A. Individual sensitivity to cytogenic effects of 1, 2:3, 4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes. Pharmacogenetics, 8: 461-471, 1998
41. Uusküla, M., Järventaus, H., Hirvonen, A., Sorsa, M., and Norppa, H. Influence of GSTM1 genotype on sister chomatid exchange induction by styrene-7, 8-oxide and epoxy-3-butene in cultured human lymphocytes. Carcinogenesis (Lond.), 16: 947-950, 1995
42. Sasiadek, M., Hirvonen, A., Noga, L., Paprocka-Borowicz, M., and Norppa, H. Glutathione S-transferase M1 genotype influences sister chromatid exchange induction but not adaptive response in human lymphocytes treated with 1, 2-epoxy-3-butene. Mutat. Res., 439: 207-212, 1999
43. Schlade-Bartusiak, K., Sasiadek, M., and Kozlowska, J. The influence of GSTM1 and GSTT1 genotypes on the induction of sister chromatid exchanges and chromosomal aberrations by 1, 2:3, 4-diepoxybutane. Mutat. Res., 465: 69-75, 2000
44. Sorsa, M., Osterman-Golkar, S., Peltonen, K., Saarikoski, S. T., and Srám, R. J. Assessment of exposure to butadiene in the process industry. Toxicology, 113: 77-83, 1996
45. Srám, R. J., Rossner, P., Peltonen, K., Podrazilova, K., Mrackova, G., Demopoulos, N. A., Stephanou, G., Vlachodimitropoulos, D., Darroundi, F., and Tates, A. D. Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay parameters in 1, 3-butadiene-exposed workers. Mutat. Res., 419: 145-154, 1998
46. Zhao, C., Vodicka, P., Srám, R. J., and Hemminki, K. DNA adducts of 1, 3-butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ. Mol. Mutagen., 3: 226-230, 2001
47. Abdel-Rahman, S. Z., Ammenheuser, M. M., and Ward, J. B. Human sensitivity to 1, 3-butadiene: role of microsomal epoxide hydrolase polymerphisms. Carcinogenesis (Lond.), 22: 415-423, 2001
48. National Institute of Occupational Safety and Health, Cincinnati, OH, NIOSH. 1, 3-Butadiene, Method 1024. Manual of Analytical Methods, Ed. 4. 1994
49. Sabourin, P. J., Burka, L. T., Bechtold, W. E., Dahl, A. R., Hoover, M. D., Chang, I. Y., and Henderson, R. F. Species differences in urinary butadiene metabolites: identification of 1, 2-dihydroxy-4-(N-acetylcysteinyl)butane, a novel metabolite of butadiene. Carcinogenesis (Lond.), 13: 1633-1638, 1992
50. Bader, M., Lewalter, J., and Angerer, J. Analysis of N-alkylated amino acids in humans hemoglobin: evidence for elevated N-methylvaline level in smokers. Int. Arch. Occup. Environ. Health, 67: 237-242, 1995
51. Miller, S. A., Dykes, D. D., and Polesky, H. F. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res., 16: 1215, 1988
52. Persson, I., Johansson, I., Bergling, H., Dahl, M. L., Seidegard, J., Rylander, R., Rannung, A., Högberg, J., and Ingelman-Sundberg, M. Genetic polymorphism of cytochrome P4502E1 in Swedish population. Relationship to incidence of lung cancer. FEBS Lett., 319: 207-211, 1993
53. Fairbrother, K., Grove, J., de Waziers, I., Steimel, T., Day, C. P., Crespi, C., and Daly, A. K. Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics, 8: 543-552, 1998
54. Hu, Y., Hakkola, J., Oscarson, M., and Ingelman-Sundberg, M. Structural and functional characterization of the 5′-flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene. Biochem. Biophys. Res. Commun., 263: 286-293, 1999
55. Fritsche, E., Pittman, G. S., and Bell, D. A. Localization, sequence analysis, and ethnic distribution of a 96-bp insertion in the promoter of the human CYP2E1 gene. Mutat. Res., 432: 1-5, 2000
56. Brockmöller, J., Gross, D., Kreb, R., Drakoulis, N., and Roots, I. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction. Biochem. Pharmacol., 43: 647-650, 1992
57. Pemble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E., and Bolt, H. M. Human glutathione S-transferase θ (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J., 300: 271-276, 1994
58. Warholm, M., Rane, A., Alexandrie, A. K., Monaghan, G., and Rannung, A. Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish population. Pharmacogenetics. 5: 252-254. 1995
59. Carstensen, U., Hou, S. M., Alexandrie, A. K., Högstedt, B., Tagesson, C. Warholm, M., Rannung, A., Lambert, B., Axmon, A., and Agmar, L. Influence of genetic polymorphisms of biotransformation enzymes on gene mutations, strand breaks of deoxyribonucleic acid, and micronuclei in mononuclear blood cells and urinary 8-hydroxydeoxyguanosine in potroom workers exposed to polyaromatic hydrocarbons. Scand. J. Work. Environ. Health, 25: 351-360, 1999
60. Hassett, C., Aicher, L, Sidhu, J. S., and Omiecinski, C. J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet., 3: 421-428, 1994
61. Chao, Y. C., Wang, M. F., Tang, H. S., Hsu, C. T., and Yin, S. J. Genotyping of alcohol dehydrogenase at the ADH2 and ADH3 loci by using polymerase chain reaction and restriction-fragment-length polymorphism in Chinese alcoholic cirrhotics and non-alcoholics. Proc. Natl. Sci. Counc. Repub. China B, Life Sci. 16: 101-106, 1994
62. Osier, M., Pakstis, A. J., Kidd, J. R., Lee, J. F., Yin, S. J., Ko, H. C., Edenberg, H. J., Lu, R. B., and Kidd, K. K. Linkage disequilibrium at the ADH2 and ADH3 loci and risk of alcoholism. Am. J. Hum. Genet., 64: 1147-1157, 1999
63. Garte, S., Gaspari, L., Alexandrie, A-K., Ambrosone, C., Autrup, H., Autrup, J. L., Baranova, H., Bathum, L., Benhamou, S., Boffetta, P., Bouchardy, C., Breskvar, K., Brockmoller, J., Cascorbi, I., Clapper, M. L., Coutelle, C., Daly, A., Dell'Omo, M., Dolzan, V., Dresler, C. M., Fryer, A., Haugen, A., Hein, D. W., Hildesheim, A., Hirvonen, A., Hsieh, L-L., Ingelman-Sundberg, M., Kalina, I., Kang, D., Kihara, M., Kiyohara, C., Kremers, P., Lazarus, P., Le Marchand, L., Lechner, M. C., van Lieshout, E. M., London, S., Manni, J. J., Maugard, C. M., Morita, S., Nazar-Stewart, V., Noda, K., Oda, Y., Parl, F. F., Pastorelli, R., Persson, I., Peters, W. H. M., Rannug, A., Rebbeck, T., Risch, A., Roelandt, L., Romkes, M., Ryberg, D., Salagovic, J., Schoket, B., Seidegard, J., Shields, P. G., Sim, E., Sinnet, D., Strange, R. C., Stucker, I., Sugimura, H., To-Figueras, J., Vineis, P., Yu, M. C., and Taioli, E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomark. Prev., 10: 1239-1248, 2001